Kuchyne na miru


May 15, 2019
FDA is examining and updating its programs for overseeing global operations and international affairs.
May 08, 2019
Pharmaceutical Executive
Interviews spotlighting the changing dynamics for C-suite business managers in two contrasting life sciences settings—big, established pharma and small, aggressive biotech.
May 01, 2019
Ed Schoonveld reviews the key topics discussed at the World Health Organization's second Fair Pricing Forum, held in Johannesburg, South Africa last month.
Apr 29, 2019
The UK has had in place what amount to two pricing schemes for branded medicines for years. But with major changes to both schemes set out in 2018, it’s now a new tale of two pricing schemes. Leela Barham reports.
Apr 06, 2019
Pharmaceutical Executive
Europe slow to action on emerging technologies, but the complex issues clouding EHRs and gene editing, for example, offer pause.
Apr 03, 2019
Jianan Huang analyses the use of external innovation tools among small and large pharma in China.
Mar 20, 2019
Pharmaceutical Executive
Eli Lilly's Michael W. Magdycz discusses the ways in which country-level leaders approach governance and decision-making.
Mar 07, 2019
Pharmaceutical Executive
Despite a “temporary fix” at the ready, pharma supply repercussions loom if exit deal isn’t reached this month.
Feb 19, 2019
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Dr. Lingshi Tan, chairman and CEO of Shanghai-based CRO dMed Company Limited, discusses China's regulatory evolution and the opportunities to strengthen collaborations with FDA and other global agencies.
Feb 10, 2019
Pharmaceutical Executive
How innovation growth has upped the pressure on China to compete globally, forcing upgrades in regulatory, quality, and standards.


У нашей фирмы популярный портал про направление https://uniti.ua.
lorem ipsum